Literature DB >> 15198513

Encapsulation of water-insoluble drug by a cross-linking technique: effect of process and formulation variables on encapsulation efficiency, particle size, and in vitro dissolution rate.

Pralhad T Tayade1, Rajendrakumar D Kale.   

Abstract

Ibuprofen-gelatin micropellets were prepared by the cross-linking technique using formaldehyde. Spherical micropellets having an entrapment efficiency of 65% to 85% were obtained. The effect of core to coat ratio, speed of agitation, temperature, and volume of oil phase was studied with respect to entrapment efficiency, micropellet size, and surface characteristics. Fourier transform infrared spectroscopy and differential scanning calorimetric analysis confirmed the absence of any drug-polymer interaction. X-ray diffraction patterns showed that there is a decrease in crystallinity of the drug. The micromeritic properties of micropellets were found to be slightly changed by changing various processing parameters to give micropellets of good flow property. The in vitro release profile could be altered significantly by changing various processing parameters to give a controlled release of drug from the micropellets. The stability studies of the drug-loaded micropellets showed that the drug was stable at storage conditions of room temperature, 37 degrees C, 25 degrees/60% relative humidity (RH) and 45 degrees/60% RH, for 12 weeks.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15198513      PMCID: PMC2750947          DOI: 10.1208/ps060112

Source DB:  PubMed          Journal:  AAPS PharmSci        ISSN: 1522-1059


  4 in total

1.  A new oral gelatinized sustained-release dosage form.

Authors:  N TANAKA; S TAKINO; I UTSUMI
Journal:  J Pharm Sci       Date:  1963-07       Impact factor: 3.534

2.  Porous biodegradable microspheres for controlled drug delivery. I. Assessment of processing conditions and solvent removal techniques.

Authors:  T Sato; M Kanke; H G Schroeder; P P DeLuca
Journal:  Pharm Res       Date:  1988-01       Impact factor: 4.200

3.  Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics.

Authors:  N Wakiyama; K Juni; M Nakano
Journal:  Chem Pharm Bull (Tokyo)       Date:  1981-11       Impact factor: 1.645

4.  Characterization of polymorphs of tranilast anhydrate and tranilast monohydrate when crystallized by two solvent change spherical crystallization techniques.

Authors:  Y Kawashima; T Niwa; H Takeuchi; T Hino; Y Itoh; S Furuyama
Journal:  J Pharm Sci       Date:  1991-05       Impact factor: 3.534

  4 in total
  6 in total

1.  Encapsulation and characterization of controlled release flurbiprofen loaded microspheres using beeswax as an encapsulating agent.

Authors:  Nazar M Ranjha; Hafeezullah Khan; Shahzad Naseem
Journal:  J Mater Sci Mater Med       Date:  2010-03-10       Impact factor: 3.896

2.  Furosemide-loaded Alginate Microspheres Prepared by Ionic Cross-linking Technique: Morphology and Release Characteristics.

Authors:  M K Das; P C Senapati
Journal:  Indian J Pharm Sci       Date:  2008-01       Impact factor: 0.975

3.  Comparison and suitability of gel matrix for entrapping higher content of enzymes for commercial applications.

Authors:  R Mahajan; V K Gupta; J Sharma
Journal:  Indian J Pharm Sci       Date:  2010-03       Impact factor: 0.975

4.  Calcium Alginate-Neusilin US2 Nanocomposite Microbeads for Oral Sustained Drug Delivery of Poor Water Soluble Drug Aceclofenac Sodium.

Authors:  Manjanna Kolammanahalli Mallappa; Rajesh Kesarla; Shivakumar Banakar
Journal:  J Drug Deliv       Date:  2015-02-23

5.  Maximizing the encapsulation efficiency and the bioavailability of controlled-release cetirizine microspheres using Draper-Lin small composite design.

Authors:  Khalid Mohamed El-Say
Journal:  Drug Des Devel Ther       Date:  2016-02-24       Impact factor: 4.162

6.  Formulation and evaluation of mouth disintegrating tablets of atenolol and atorvastatin.

Authors:  R M Sarfraz; H U Khan; A Mahmood; M Ahmad; S Maheen; M Sher
Journal:  Indian J Pharm Sci       Date:  2015 Jan-Feb       Impact factor: 0.975

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.